Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 23 10:37AM ET
103.96
Dollar change
+0.24
Percentage change
0.23
%
IndexS&P 500 P/E32.78 EPS (ttm)3.17 Insider Own0.72% Shs Outstand1.73B Perf Week1.21%
Market Cap180.85B Forward P/E20.21 EPS next Y5.14 Insider Trans-0.73% Shs Float1.73B Perf Month-1.66%
Income5.54B PEG4.05 EPS next Q1.20 Inst Own76.42% Short Float0.75% Perf Quarter-2.90%
Sales40.73B P/S4.44 EPS this Y4.87% Inst Trans0.27% Short Ratio2.19 Perf Half Y-8.96%
Book/sh22.31 P/B4.66 EPS next Y10.49% ROA7.67% Short Interest13.00M Perf Year-9.04%
Cash/sh3.82 P/C27.19 EPS next 5Y8.10% ROE14.80% 52W Range89.67 - 121.64 Perf YTD-5.55%
Dividend Est.2.16 (2.08%) P/FCF36.74 EPS past 5Y19.65% ROI10.78% 52W High-14.53% Beta0.72
Dividend TTM2.16 (2.08%) Quick Ratio1.11 Sales past 5Y6.10% Gross Margin57.86% 52W Low15.93% ATR (14)1.92
Dividend Ex-DateJul 15, 2024 Current Ratio1.60 EPS Y/Y TTM-2.49% Oper. Margin16.33% RSI (14)51.30 Volatility2.53% 1.78%
Employees114000 Debt/Eq0.38 Sales Y/Y TTM1.24% Profit Margin13.61% Recom1.74 Target Price124.73
Option/ShortYes / Yes LT Debt/Eq0.32 EPS Q/Q-5.00% Payout63.81% Rel Volume0.71 Prev Close103.72
Sales Surprise0.08% EPS Surprise3.17% Sales Q/Q4.00% EarningsJul 18 BMO Avg Volume5.92M Price103.96
SMA200.52% SMA500.12% SMA200-2.48% Trades Volume902,105 Change0.23%
Date Action Analyst Rating Change Price Target Change
May-30-24Initiated Goldman Buy $121
Jul-21-23Upgrade Wolfe Research Underperform → Peer Perform
May-30-23Downgrade Morgan Stanley Overweight → Equal-Weight $112
Apr-20-23Reiterated Wolfe Research Underperform $107 → $103
Apr-20-23Reiterated UBS Buy $117 → $130
Apr-20-23Reiterated Raymond James Outperform $116 → $123
Apr-20-23Reiterated JP Morgan Overweight $118 → $122
Apr-20-23Reiterated Bernstein Outperform $132 → $133
Apr-20-23Reiterated Barclays Overweight $125 → $127
Mar-29-23Initiated UBS Buy $117
Jul-20-24 08:45PM
07:00AM
Jul-19-24 12:33PM
03:11AM
Jul-18-24 06:16PM
04:17PM Loading…
04:17PM
03:00PM
02:34PM
01:57PM
01:39PM
11:55AM
11:06AM
10:32AM
09:54AM
09:30AM
08:45AM Loading…
08:45AM
07:43AM
07:42AM
07:32AM
07:30AM
06:01AM
Jul-13-24 11:00AM
Jul-11-24 10:28AM
09:30AM
09:00AM
08:00AM
Jul-10-24 03:22PM
Jul-09-24 06:00PM
Jul-04-24 07:03PM
03:54PM
06:35AM Loading…
06:35AM
Jul-02-24 04:45PM
Jul-01-24 06:00AM
Jun-28-24 07:28PM
09:00AM
Jun-27-24 08:00AM
Jun-26-24 08:00AM
06:48AM
Jun-25-24 06:00PM
Jun-24-24 11:40AM
11:25AM
09:30AM
Jun-21-24 12:24PM
11:13AM
11:10AM
11:08AM
11:02AM
10:58AM
10:56AM
Jun-20-24 11:02AM
09:25AM
08:05AM
05:15AM
Jun-18-24 03:51PM
Jun-17-24 06:00PM
09:00AM
Jun-14-24 12:01PM
Jun-13-24 02:26PM
Jun-12-24 09:43AM
09:33AM
08:15AM
08:00AM
07:45AM
Jun-11-24 05:50PM
01:02PM
09:45AM
08:15AM
Jun-10-24 04:04PM
02:55PM
Jun-09-24 09:00AM
Jun-07-24 05:16PM
07:10AM
Jun-06-24 02:32PM
02:25PM
09:30AM
Jun-05-24 05:50PM
09:00AM
Jun-03-24 03:51PM
09:00AM
May-31-24 12:20PM
12:18PM
May-30-24 05:50PM
02:33PM
08:00AM
05:50AM
May-29-24 04:58PM
02:30PM
May-28-24 06:45AM
May-27-24 12:46PM
12:39PM
May-24-24 05:50PM
May-22-24 05:17PM
09:31AM
May-21-24 09:30AM
09:29AM
08:45AM
May-20-24 02:47PM
May-17-24 11:30AM
May-16-24 08:00AM
May-15-24 10:41AM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Funck, Jr. Robert E.EXECUTIVE VICE PRESIDENTMay 10 '24Option Exercise47.0010,097474,559221,438May 14 05:35 PM
Funck, Jr. Robert E.EXECUTIVE VICE PRESIDENTMay 10 '24Sale104.5710,0971,055,819211,341May 14 05:35 PM
Earnhardt Lisa DEXECUTIVE VICE PRESIDENTMay 07 '24Sale106.2522,8522,428,11961,462May 08 05:00 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.50963114,116125,697Mar 04 07:18 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.50853101,080184,806Mar 04 06:39 PM
Morrone Louis H.EXECUTIVE VICE PRESIDENTMar 01 '24Sale118.5080194,91862,968Mar 04 07:14 PM
Earnhardt Lisa DEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.5069482,23984,314Mar 04 06:50 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.5067680,10691,260Mar 04 07:09 PM
MCCOY JOHN A. JR.VICE PRESIDENTMar 01 '24Sale118.5047255,93218,760Mar 04 07:05 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTFeb 23 '24Option Exercise59.9412,500749,25091,204Feb 27 06:13 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTFeb 23 '24Sale120.0012,5001,500,00078,704Feb 27 06:13 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTJan 29 '24Option Exercise50.8042,5002,158,95090,027Jan 31 05:30 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTJan 29 '24Sale112.5042,5004,781,25065,027Jan 31 05:30 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 14 '23Option Exercise44.4015,000666,00080,027Dec 18 05:36 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 14 '23Sale108.0015,0001,620,00065,027Dec 18 05:36 PM
STARKS DANIEL JDirectorOct 26 '23Sale94.0550,0004,702,5266,725,316Oct 30 04:58 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTAug 08 '23Option Exercise38.405,000192,00075,427Aug 10 06:31 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTAug 08 '23Sale105.0310,4001,092,29765,027Aug 10 06:31 PM
STARKS DANIEL JDirectorJul 27 '23Sale113.7650,0005,688,1896,775,316Jul 28 05:10 PM